Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial

Author： Scirica Benjamin   Cannon Christopher   Cooper Richard   Aster Richard   Brassard Jacqueline   McCabe Carolyn   Charlesworth Andrew   Skene Allan   Braunwald Eugene  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.22, Iss.2, 2006-10, pp. : 95-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes

By Viswanathan Girish   Kidambi Ananth   Nelson Adam   Mayurathan Gnanamoorthy   Hardy John   Kesteven Patrick   Zaman Azfar  

Platelets, Vol. 23, Iss. 3, 2012-05 ,pp. : 224-228

Informa Healthcare

Access to resources Recommend Favorite

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

By Akkerhuis K.M.  

European Heart Journal, Vol. 21, Iss. 5, 2000-03 ,pp. : 371-381

Oxford University Press

Access to resources Recommend Favorite

The Effect of Glycoprotein IIb/IIIa Receptor Inhibitor on the Microcirculation in Patients Undergoing High-Risk Coronary Stenting; A Prospective, Randomized Study

By Wong Philip   Harding Scott   Inglessis Ignacio   Choi C. Joon   Walters Darren   Chang Yuchiao   Gimelli Giogio   Jang Ik-Kyung  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 163-166

Springer Publishing Company

Access to resources Recommend Favorite

Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative

By Singh Kanwar   Roe Matthew   Peterson Eric   Chen Anita   Mahaffey Kenneth   Goodman Shaun   Harrington Robert   Smith Sidney   Gibler W.   Ohman E.   Pollack Charles  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Blockers in Non-ST Elevation Acute Coronary Syndromes: Only for Well Defined Subgroups or a Therapeutic Option for All Patients?

By Verheugt Freek W.A.  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite